Llwytho...
Risk of jaw osteonecrosis after intravenous bisphosphonates in cancer patients and patients without cancer
OBJECTIVE: To compare the risk of jaw osteonecrosis after intravenous (IV) bisphosphonate administered to patients with cancer versus to non-cancer patients. PATIENTS AND METHODS: We conducted a retrospective cohort study of a 5% national sample of Medicare patients administered IV bisphosphonate fr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mayo Clin Proc |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5219844/ https://ncbi.nlm.nih.gov/pubmed/27876314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2016.09.015 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|